Skip to main content
. 2016 Dec 29;15(2):613–626. doi: 10.3892/mmr.2016.6083

Table I.

Comparison of liver function in the control and model groups.

Group n ALT (IU/l) AST (IU/l) Alb (g/l) TBIL (umol/l) DBIL (umol/l) CHE (U/l) ALP (IU/l) GGT (IU/l)
Control 20 33.67±2.16 132.83±2.85 37.38±1.11 0.95±0.19 0.3±0.14 56.33±5.32 87.13±0.61 1.00±0.00
Model week 1 10 61.40±5.32a 148.8±3.19a 34.82±0.26a 1.88±0.38a 0.6±0.16a 50.88±0.40 114.32±3.06a 1.15±0.04a
Model week 2 10 80.29±37.63a 164.00±12.32a,b 32.27±2.39a,b 2.97±1.40a 0.83±0.42a 45.79±0.99a,b 138.00±7.23a,b 1.31±0.18a
Model week 3 10 104.20±4.66a 318.00±27.06a,c 27.12±0.29a,c 3.20±0.26a 1.16±0.43a 38.74±0.32a,c 164.72±3.15a,c 1.61±0.04a,c
Model week 4 10 138.25±9.32a,d 484.75±89.46a,d 20.60±0.32a,d 3.83±0.49a,d 1.65±0.21a 35.75±6.40a 183.75±2.50a,d 1.80±0.59

Data are presented as the mean ± standard deviation.

a

P<0.05 vs. control

b

P<0.05 vs. model week 1

c

P<0.05 vs. model week 2

d

P<0.05 vs. model week 3. ALT, alanine aminotransferase; AST, aspartate aminotransferase; Alb, albumin; TBil, total bilirubin; DBil, direct bilirubin; CHE, cholinesterase; ALP, alkaline phosphatase; GGT, gamma-glutamyltranspeptidase.